Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
47.78
-0.18 (-0.38%)
Dec 29, 2025, 2:37 PM EST - Market open
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.53 billion as of December 29, 2025. Its market cap has decreased by -14.48% in one year.
Market Cap
4.53B
Enterprise Value
3.51B
1-Year Change
-14.48%
Ranking
Category
Stock Price
$47.78
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.53B, an increase of 704.00%. That is a compound annual growth rate of 32.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 4.55B | -4.02% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | 464.53M | -23.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |